A pilot study led by Dr. Dallery tested psilocybin‑assisted therapy in patients with binge eating disorder (BED) and reported reductions in binge episodes and improvements in eating-related outcomes. The randomized, early-phase work, published in the Journal of Eating Disorders, explores feasibility, safety, and preliminary efficacy in a controlled clinical setting. Investigators emphasize small sample size and the exploratory nature of the trial; nonetheless, the results support further randomized, powered studies to evaluate sustained efficacy, optimal dosing, and integration with psychotherapy. The study adds to a growing pipeline of psychedelic-assisted interventions targeting compulsive and compulsive‑related psychiatric disorders.